Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Hematology and Oncology"
DOI: 10.1080/08880018.2021.1901809
Abstract: Abstract This study was organized to determine the efficacy and safety of deferasirox (DFX) in reducing the SF of patients with transfusion-dependent thalassemia (TDT). This is a retrospective, descriptive study of 101 transfusion- dependent patients… read more here.
Keywords: safety; transfusion dependent; efficacy; transfusion ... See more keywords
Immune response and adverse events after vaccination against SARS‐CoV‐2 in adult patients with transfusion‐dependent thalassaemia
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18146
Abstract: Patients with transfusion‐dependent thalassaemia (TDT) are considered an at increased‐risk population for severe and/or morbid coronavirus disease 2019 (COVID‐19) infection. Timely vaccination is the main preventive method for severe COVID‐19. Different adverse events and reactions… read more here.
Keywords: dependent thalassaemia; adult patients; transfusion dependent; vaccination ... See more keywords
Management of luspatercept therapy in patients with transfusion‐dependent β‐thalassaemia
Sign Up to like & getrecommendations! Published in 2023 at "British Journal of Haematology"
DOI: 10.1111/bjh.18801
Abstract: Patients with transfusion‐dependent β‐thalassaemia require lifelong, regular red blood cell transfusions for survival; however, frequent blood transfusions are associated with an increased risk of iron overload, transfusion‐transmitted disease and alloimmunization, as well as reduced quality… read more here.
Keywords: dependent thalassaemia; transfusion dependent; patients transfusion; management ... See more keywords
Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
Sign Up to like & getrecommendations! Published in 2020 at "BMC Ophthalmology"
DOI: 10.1186/s12886-020-01647-y
Abstract: Background Ocular involvement may occur via several mechanisms in patients with transfusion-dependent β-thalassemia (TDT) mainly chronic anemia, iron overload and iron chelator toxicity. We aimed to evaluate the frequency of abnormal ocular findings and their… read more here.
Keywords: thalassemia; transfusion dependent; southern iran; ocular findings ... See more keywords